| |
| |
|
| Insider
Information: |
Arbuckle Stuart A |
| Relationship: |
Director |
| City: |
Cambridge, |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
62,795 |
|
|
Indirect Shares
|
140 |
|
|
| Direct
Value |
$21,012,430 |
|
|
|
Indirect Value
|
$59,189 |
|
|
| Total
Shares |
62,935 |
|
|
| Total
Value |
$21,071,619 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-02-26 |
49,691 |
2024-02-26 |
140 |
Premium* |
|
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
191 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2021-11-15 |
4 |
AS |
$186.99 |
$562 |
D/D |
(3) |
41,103 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2020-11-16 |
4 |
AS |
$222.47 |
$1,565 |
D/D |
(7) |
35,179 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2019-11-15 |
4 |
AS |
$205.95 |
$3,913 |
D/D |
(19) |
33,240 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2018-11-15 |
4 |
AS |
$163.75 |
$4,749 |
D/D |
(29) |
46,752 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2017-11-15 |
4/A |
AS |
$147.29 |
$7,070 |
D/D |
(48) |
41,952 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-08-10 |
4 |
OE |
$155.57 |
$9,956 |
D/D |
64 |
61,060 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-05-30 |
4 |
AS |
$329.82 |
$27,045 |
D/D |
(82) |
56,556 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Comm & Ops Officer |
• – – |
2021-05-17 |
4 |
AS |
$215.33 |
$23,589 |
D/D |
(109) |
41,103 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2020-05-15 |
4 |
AS |
$276.35 |
$32,089 |
D/D |
(113) |
35,179 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2019-05-15 |
4 |
AS |
$165.41 |
$22,000 |
D/D |
(133) |
33,240 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-05-16 |
4 |
AS |
$246.21 |
$33,408 |
D/D |
(133) |
64,760 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2018-05-15 |
4 |
AS |
$155.78 |
$21,498 |
D/D |
(138) |
46,752 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-05-15 |
4 |
AS |
$123.85 |
$18,330 |
D/D |
(148) |
127,515 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-04-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
138,120 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2016-05-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
115,774 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-08-10 |
4 |
AS |
$300.32 |
$54,073 |
D/D |
(180) |
60,880 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2017-11-15 |
4 |
AS |
$147.29 |
$32,551 |
D/D |
(221) |
41,952 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2019-05-03 |
4 |
AS |
$170.28 |
$40,867 |
D/D |
(240) |
34,553 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-05-02 |
4 |
AS |
$263.98 |
$80,778 |
D/D |
(306) |
64,760 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2013-07-29 |
4 |
AS |
$79.87 |
$27,715 |
D/D |
(347) |
51,751 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-12-29 |
4 |
A |
$29.65 |
$13,105 |
D/D |
442 |
5,381 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-06-30 |
4 |
A |
$18.87 |
$13,115 |
D/D |
695 |
4,112 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-09-29 |
4 |
A |
$15.87 |
$13,124 |
D/D |
827 |
4,939 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2016-10-03 |
4 |
AS |
$86.46 |
$104,444 |
D/D |
(1,208) |
114,566 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2016-11-09 |
4 |
AS |
$90.00 |
$108,720 |
D/D |
(1,208) |
113,358 |
0 |
- |
|
191 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
